ADX-47273
Experimental drug for the treatment of schizophrenia
ADX-47273 is an experimental drug that has been investigated for its potential use in the treatment of schizophrenia. It is a positive allosteric modulator of the metabotropic glutamate receptor 5 (mGluR5), which plays a role in modulating glutamate neurotransmission in the central nervous system.
Mechanism of Action[edit | edit source]
ADX-47273 works by enhancing the activity of mGluR5, a receptor that is involved in the regulation of synaptic plasticity and neurotransmitter release. By modulating this receptor, ADX-47273 may help to correct the glutamatergic dysfunction that is believed to contribute to the symptoms of schizophrenia.
Potential Therapeutic Use[edit | edit source]
The primary therapeutic application of ADX-47273 is in the treatment of schizophrenia, a chronic and severe mental disorder characterized by delusions, hallucinations, and cognitive impairment. Current treatments for schizophrenia primarily target the dopamine system, but there is a growing interest in developing drugs that target the glutamatergic system, such as ADX-47273.
Clinical Trials[edit | edit source]
As of the latest updates, ADX-47273 has undergone clinical trials to evaluate its safety, tolerability, and efficacy in patients with schizophrenia. The results of these trials are crucial in determining whether ADX-47273 can be developed into a viable treatment option for this condition.
Research and Development[edit | edit source]
The development of ADX-47273 is part of a broader effort to explore new therapeutic targets for the treatment of schizophrenia and other neuropsychiatric disorders. Research in this area is ongoing, with the aim of improving outcomes for patients who do not respond adequately to existing treatments.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
